EyePoint Pharmaceuticals Income Statement (2010-2019) | EYPT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019
Revenue & cost
Revenue 0.48M0.41M0.36M3.30M0.00M0.63M0.54M0.70M0.55M0.58M0.51M0.49M0.60M0.59M1.99M0.29M25.31M0.52M0.33M0.41M0.47M0.53M0.32M0.30M0.28M5.97M0.59M0.70M0.39M0.10M0.93M0.71M0.49M
Cost of Revenue 3.65M
Gross Profit -3.16M
Operating items
Research & Development 1.74M1.53M1.74M1.85M2.13M1.99M1.51M1.41M1.52M1.57M1.59M2.32M2.50M2.49M2.27M2.31M2.78M2.77M3.34M3.20M3.48M3.72M3.07M4.10M4.18M3.17M3.32M4.21M3.82M4.27M3.33M4.76M6.23M
Selling, General & Administrative 2.17M2.00M1.76M2.17M2.06M1.45M1.76M1.60M1.62M1.66M1.74M2.15M1.81M1.71M1.95M2.00M1.73M1.87M2.04M2.41M1.97M2.04M2.35M2.66M3.29M2.90M2.43M2.62M2.57M2.47M2.28M4.22M4.16M
Other Operating Expenses 14.83M-0.07M-0.00M-0.00M1.51M3.65M
Operating Expenses 3.91M3.54M3.50M4.02M4.19M18.27M3.27M3.01M3.14M3.23M3.33M4.47M4.32M4.13M4.21M4.30M4.52M4.64M5.38M5.61M5.45M5.76M5.42M6.76M7.46M6.07M5.75M6.84M6.39M6.74M5.61M10.50M14.04M
Operating Income -3.44M-3.12M-3.14M-0.31M-2.53M-17.64M-2.73M-2.31M-2.59M-2.65M-2.81M-3.98M-3.72M-3.54M-2.22M-4.01M20.79M-4.12M-5.05M-5.20M-4.98M-5.24M-5.10M-6.46M-7.19M-0.09M-5.16M-6.14M-6.01M-5.81M-4.68M-9.78M-13.55M
EBIT -3.44M-3.12M-3.14M-0.31M-2.53M-17.64M-2.73M-2.31M-2.59M-2.65M-2.81M-3.98M-3.72M-3.54M-2.22M-4.01M20.79M-4.12M-5.05M-5.20M-4.98M-5.24M-5.10M-6.46M-7.19M-0.09M-5.16M-6.14M-6.01M-5.81M-4.68M-9.78M-13.55M
Non-operating items
Non Operating Investment Income -0.00M0.01M0.00M-0.00M0.01M-0.01M0.00M-0.00M0.00M-0.00M-0.00M0.00M0.00M-0.01M0.01M-0.01M0.00M-2.30M-22.78M-18.89M
Interest & Investment Income 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M
Other Non Operating Income 0.34M0.46M0.33M0.01M0.04M0.13M0.00M-0.00M-0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.02M0.03M0.02M0.03M0.02M0.02M0.02M0.03M0.03M0.03M0.13M
Non Operating Income 0.34M0.46M0.34M0.02M0.05M0.14M0.01M0.96M0.01M0.00M0.00M0.13M0.00M0.00M0.00M0.15M0.00M0.00M0.01M0.12M0.01M0.01M0.02M0.74M0.02M0.03M0.02M-0.19M0.02M0.03M0.03M0.03M0.13M
Net income details
EBT -3.10M-2.66M-2.80M-0.29M-2.48M-17.50M-2.72M-2.30M-2.58M-2.65M-2.81M-3.98M-3.72M-3.54M-2.22M-4.01M20.79M-4.11M-5.04M-3.52M-4.97M-5.23M-5.08M-6.42M-7.16M-0.07M-5.14M-6.12M-6.01M-5.81M-4.68M-9.78M-14.37M
Tax Provisions 0.01M0.04M-0.11M-0.15M0.06M-0.04M-0.03M-0.04M-0.03M-0.04M-0.01M-0.03M-0.03M-0.03M-0.03M-0.04M0.23M-0.04M-0.04M-0.05M-0.04M-0.04M-0.03M-0.04M
Profit After Tax -3.11M-2.69M-2.69M-0.14M-2.43M-17.46M-2.69M-2.26M-2.55M-2.61M-2.79M-3.95M-3.69M-3.51M-2.19M-3.97M20.57M-4.08M-5.00M-5.15M-4.93M-5.19M-5.04M-6.39M-7.16M-0.07M-5.14M-6.12M-5.98M-5.78M-6.98M-34.43M-33.13M
Income from Continuing Operations -3.11M-2.69M-2.69M-0.14M-2.54M-17.46M-2.69M-2.26M-2.55M-2.61M-2.79M-3.95M-3.69M-3.51M-2.19M-3.97M20.57M-4.08M-5.00M-3.47M-4.93M-5.19M-5.04M-6.39M-7.16M-0.07M-5.14M-6.12M-6.01M-5.81M-4.68M-9.78M-14.37M
Consolidated Net Income -3.11M-2.69M-2.69M-0.14M-2.54M-17.46M-2.69M-2.26M-2.55M-2.61M-2.79M-3.95M-3.69M-3.51M-2.19M-3.97M20.57M-4.08M-5.00M-3.47M-4.93M-5.19M-5.04M-6.39M-7.16M-0.07M-5.14M-6.12M-6.01M-5.81M-4.68M-9.78M-14.37M
Income towards Parent Company -3.11M-2.69M-2.69M-0.14M-2.54M-17.46M-2.69M-2.26M-2.55M-2.61M-2.79M-3.95M-3.69M-3.51M-2.19M-3.97M20.57M-4.08M-5.00M-3.47M-4.93M-5.19M-5.04M-6.39M-7.16M-0.07M-5.14M-6.12M-6.01M-5.81M-4.68M-9.78M-14.37M
Net Income towards Common Stockholders -3.11M-2.69M-2.69M-0.14M-2.54M-17.46M-2.69M-2.26M-2.55M-2.61M-2.79M-3.95M-3.69M-3.51M-2.19M-3.97M20.57M-4.08M-5.00M-3.47M-4.93M-5.19M-5.04M-6.39M-7.16M-0.07M-5.14M-6.12M-6.01M-5.81M-4.68M-9.78M-14.37M
Additional items
EPS (Basic) -0.17-0.15-0.130.01-0.12-0.84-0.13-0.11-0.11-0.11-0.12-0.17-0.14-0.13-0.08-0.140.70-0.14-0.17-0.17-0.17-0.18-0.15-0.19-0.21-0.02-0.15-0.16-0.15-0.13-0.15-0.62-0.44
EPS (Weighted Average and Diluted) -0.01-0.11-0.14-0.13-0.08-0.140.67-0.14-0.17-0.17-0.17-0.18-0.15-0.19
Shares Outstanding (Weighted Average) 1.85M1.85M2.07M2.07M2.08M2.08M2.08M2.08M2.33M2.33M2.33M2.33M2.68M2.70M2.74M2.93M2.93M2.93M2.94M2.94M2.94M2.94M3.41M3.42M3.42M3.42M3.42M3.93M3.94M4.53M4.53M5.40M7.45M9.49M9.54M
Shares Outstanding (Diluted Average) 19.49M20.79M
EBITDA -3.44M-3.12M-3.14M-0.31M-2.79M-17.60M-2.62M-2.31M-2.48M-2.62M-2.88M-3.94M-3.62M-3.48M-2.18M-3.94M20.51M-4.12M-5.04M-5.10M-4.96M-5.21M-5.05M-6.42M-7.18M-0.08M-5.14M-6.11M-5.98M-5.78M-6.98M-34.43M-33.13M
Interest Expenses 0.81M
Tax Rate 4.04%51.56%0.25%1.10%1.74%1.28%1.40%0.53%0.80%0.81%0.73%1.40%1.07%1.09%0.92%0.87%1.36%0.82%0.80%0.67%0.59%